Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.2T | 1.2T | 1.1T | 1.2T |
Cost of revenue | 1.0T | 1.1T | 995.8B | 1.0T |
Gross profit | 130.2B | 156.8B | 133.5B | 217.9B |
Operating expense | ||||
Research & development | — | 3.6B | 2.6B | 3.9B |
Selling general and admin | 60.5B | 45.8B | 34.0B | 30.6B |
Other operating expenses | — | 14.7B | 982M | 691M |
Operating income | 130.2B | 33.9B | 74.4B | 161.3B |
Non operating interest income | ||||
Income | — | 2.7B | 2.5B | 2.1B |
Expense | — | 8.9B | 9.8B | 9.9B |
Other income expense | — | — | — | — |
Pretax income | 57.8B | 53.6B | 62.7B | 151.9B |
Tax provision | 16.3B | 13.3B | 15.1B | 40.6B |
Net income | 41.6B | 40.3B | 47.6B | 111.3B |
Basic EPS | 1.5K | — | 1.7K | 4.1K |
Diluted EPS | 1.5K | — | 1.7K | 4.1K |
Basic average shares | — | — | 27.3M | 27.3M |
Diluted average shares | — | — | 27.3M | 27.3M |
EBITDA | 130.2B | 95.4B | 89.6B | 197.5B |
Net income from continuing op. | — | 40.3B | 47.6B | 111.3B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |